People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

HIV continues ... Control and Prevention (CDC). "Many people who would benefit from PrEP are not receiving this highly effective medication," said John B. Wong, MD, a primary care internist ...

The authors wrote that these findings suggest that “treatment as prevention could be a viable primary HIV prevention strategy for many patients given the durability of viral suppression.” ...

An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong evidence of efficacy and safety in this ...

A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option ... lenacapavir for HIV prevention did not acquire ...

Clinicians can use encounters for gender-affirming hormone therapy as opportunities to discuss HIV prevention. The prevalence of transgender-related diagnosis codes in the United States increased ...

Lenacapavir was found to be superior to background HIV incidence and Truvada for HIV prevention ... used background HIV incidence (bHIV) as the primary comparator and F/TDF as the secondary ...

The clinic works to keep people who are HIV negative stay that way and helps people who are HIV positive, Associate Director of Prevention and Clinic Operations ... “My long-term goal is to do primary ...